BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance https://www.medrxiv.org/content/10.1101/2023.03.20.23287465
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.